Venus Remedies Ltd - VENUS REMEDIES Share Price

Sector: Pharmaceuticals | ISIN: INE411B01019

₹ 378.15 (-2.78%)

29 Nov, 2023, 12:00:00 AM

Trade

Open
₹ 399.20

Prev. Close
₹ 388.95

Turnover(lac)
₹ 0.00

Day's High
₹ 399.20

Day's Low
₹ 368.75

52 Wk High
₹ 407.05

52 Wk Low
₹ 145.80

Book Value
₹ 364.96

Face Value
₹ 10.00

Mkt. Cap (Cr.)
₹ 505.47

P/E
26.06

EPS
14.92

Div. Yield
0.00

Venus Remedies Ltd Stock View

STRONG BUY

Target | 09 Nov, 2023 388 (-0.24%)

Venus Remedies Ltd is a research-based pharmaceutical company. The Company is a global injectable manufacturer, possessing a wide product basket catering to therapeutic segments of anti-infe... Read More

Venus Remedies Ltd Corporate Actions

28 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Oct , 2023

12:00 AM

Results

View Details

15 Jul , 2023

12:00 AM

AGM

Announcement date: 15 Jul , 2023

View Details

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

Results

View Details

05 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2023

12:00 AM

Results

View Details

14 Jul , 2023

12:00 AM

BookCloser

View Details

Venus Remedies Ltd News and Update

Aster DM divests stake in Gulf business for $1 billion

8 hours ago |
10:03 PM

Alpha GCC Holdings Ltd, a wholly-owned material subsidiary of Aster DM Healthcare, manages Aster's operations in the GCC (Gulf Cooperation Council) countries.

NTPC Rewards Investors with First Interim Dividend of Rs 2,182 Crore for FY...

IIFL News Service |
24 November, 2023 |
9:56 PM

Sumit Rathod, Whole-Time Director, Flair Writing Industries Ltd

IIFL News Service |
21 November, 2023 |
9:52 PM

Exide Industries Hits 52-Week High as Delhi High Court Resolves Trademark D...

IIFL News Service |
20 November, 2023 |
9:51 PM

Venus Remedies Ltd FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Venus Remedies Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,200.85	74.84	2,85,856.77	888.63	0.97	5,019.54	100.23
Divis Laboratories Ltd	3,728.70	75.75	99,768.40	342.00	0.80	1,868.00	474.52
Cipla Ltd	1,201.90	31.41	96,240.20	1,029.69	0.71	4,166.74	320.58
Dr Reddys Laboratories Ltd	5,715.55	24.70	94,596.57	1,192.60	0.70	4,819.10	1,362.00
Torrent Pharmaceuticals Ltd	2,091.30	63.82	70,389.88	327.00	1.06	2,115.00	202.85

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Venus Remedies Ltd

Pawan Chaudhary
Chairman & Managing Director

Manu Chaudhary
Joint Managing Director

Peeyush Jain
Deputy Managing Director

Ashutosh Jain
Executive Director

Gilbert Wenzel
Independent Director

S. K. Chadha
Independent Director

Neha Kodan
Company Sec. & Compli. Officer

Navdeep Sud
Independent Director

Savita Gupta
Independent Director

Akshansh Chaudhary
Whole-time Director

Nps Monga
Independent Director

Summary

Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril.The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as WHO-GMP as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc.In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and... Read More

Reports by Venus Remedies Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Venus Remedies Ltd
Investor PresentationConference Call TranscriptConference Call Audio

CALLS						PUTS
Total OI	Chg in Ol	Chg % Ol	LTP	Chg %	Strike Price	Chg %	LTP	Chg % OI	Chg in Ol	Total OI

Venus Remedies Ltd - VENUS REMEDIES Share Price

Expiry Date:

Venus Remedies Ltd Stock View

Venus Remedies Ltd KEY RATIOS

Venus Remedies Ltd Corporate Actions

Venus Remedies Ltd News and Update

Aster DM divests stake in Gulf business for $1 billion

Knowledge Center

Venus Remedies Ltd SHAREHOLDING SNAPSHOT
29 November , 2023 | 06:18 PM

Venus Remedies Ltd FINANCIALS

Select Period:

QuickLinks for Venus Remedies Ltd.

Venus Remedies Information

Venus Remedies Financials

Venus Remedies Results

Venus Remedies News

Venus Remedies Ltd PEER COMPARISON

MORE ABOUT Venus Remedies Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Venus Remedies Ltd - VENUS REMEDIES Share Price

Expiry Date:

Venus Remedies Ltd Stock View

Venus Remedies Ltd KEY RATIOS

Venus Remedies Ltd Corporate Actions

Venus Remedies Ltd News and Update

Aster DM divests stake in Gulf business for $1 billion

Knowledge Center

Venus Remedies Ltd SHAREHOLDING SNAPSHOT 29 November , 2023 | 06:18 PM

Venus Remedies Ltd FINANCIALS

Select Period:

QuickLinks for Venus Remedies Ltd.

Venus Remedies Information

Venus Remedies Financials

Venus Remedies Results

Venus Remedies News

Venus Remedies Ltd PEER COMPARISON

MORE ABOUT Venus Remedies Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Venus Remedies Ltd SHAREHOLDING SNAPSHOT
29 November , 2023 | 06:18 PM